In our November issue of Pharmaceutical Executive
FEATURES
Cover Story
Pharm Exec's 2017 Pipeline Report
Casey McDonald
The industry is readying for a leap into a new age of complex therapies. Elaborate manufacturing and soaring drug costs, however, loom as deep chasms to cross in bridging the potential with reality. |
From the Editor
The Pipeline: Pressures from Beyond
William Looney
The influx of treatment breakthroughs and expanding science has not silenced the debate over the productivity of biopharma's R&D model, and the looming challenges for R&D decision-makers. |
CEO Snapshot: Jeremey Desai, Apotex
Surviving and Thriving in Canada
Julian Upton
Pharm Exec talks to Jeremy Desai, CEO of Apotex, Canada's largest producer of generic drugs, about how independent companies can survive in an era of consolidation and growing competition. |
Lifecycle Management
Loss of Exclusivity: Strategies to Maximize Market Value
Faith Glazier, Tom Fezza, Jodi Reynolds
Loss of exclusivity (LOE) doesn't have to be the death knell for branded drug revenue streams. The key approaches to preserving meaningful value well into the post-patent-loss future are outlined. |
Market Access Roundtable
Building Access Competencies for the Future
Boston Consulting Group
An industry-based working group presents a common standards and definition framework for “Access” competencies in pharma—as a starting point in solving the current shortage of talent and leaders for this widening set of activities. |
 |
ALSO IN THIS ISSUE
8 Winning Product Portfolio Strategies
Stan Bernard
Biopharma companies are increasingly leveraging product portfolios to own and dominate strategically important therapeutic areas …Read more
Is More Competition the Cure in Pricing Debate?
Jill Wechsler
Policymakers, payers and pharma companies weigh strategies for rationalizing drug prices …Read more
The Cancer Care Conundrum in Europe
Reflector
Cancer treatment is an increasing dilemma for EU health services as they try to balance patient care against budgetary constraints …Read more
|
|
| |
| WEBCASTS |
| How the Life Sciences Cloud Coalition Is Driving Greater Innovation and Collaboration for Sponsors |
| Supporting internal and external decision-making through effective MSL activities |
Achieving Success in the Biosimilar Market
|
Why Patient Support Programs Need a Personal Approach
|
Understanding the Chronic Disease Patient Journey in Emerging Markets
|
